Healthcare and Medical
Healthcare and Medical
home | healthcare and medical | company profile
Premium Company Profile - BioMarin Pharmaceutical Inc. (Datamonitor)
- Market: Healthcare and Medical
- Published Date: 20/11/2007
- Report Title: Premium Company Profile - BioMarin Pharmaceutical Inc.
- Table of Contents: View Table of Contents
- Report Type: Company Profile
- Country: Global
- Number of Pages: 50
Introduction
BioMarin Pharmaceutical is a specialty biopharmaceutical company focused on the development of first-to-market treatments for rare, genetic diseases. The company commercializes two enzyme replacement therapies for lysosomal storage disorders (LSD): Aldurazyme, a treatment for mucopolysaccharidoses I (marketed through a joint venture with Genzyme), and Naglazyme, a treatment for MPS VI.
Scope
Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies
Highlights
BioMarin's product portfolio comprises two approved products and multiple clinical and preclinical product candidates. Approved products include Naglazyme (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin.
BioMarin derives its revenues from product sales of Naglazyme and Orapred; royalties related to the FDA approval of the marketing application for Orapred ODT; and license and contract research revenue under its agreement with Merck Serono. The company's total revenue increased from $19 million in 2004 to $ 84 million in 2006.
BioMarin's major contributor to sales growth out to 2010 will be the product sales of Naglazyme, forecasted to increase at a CAGR of 60%, from $50 million in 2006 to $328 million in 2010. This represents an absolute growth of +279 million for the same period.
Reasons to Purchase
Access all the important information and analysis on the company in a single report Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain Gain access to company's adjusted five year financial data along with key ratios and market capitalization
Scope
Highlights
Reasons to Purchase
Purchase Information
There are various ways to purchase products from our site. Select the report title(s) you are interested in, and add it to your basket. At the Checkout page, you will be requested to submit your details. You will then have the option to pay via various methods: Debit Card ; Credit Card ; Purchase via Invoice (inc. Purchase Order no. if required) and Paypal. Companiesandmarkets.com accepts Visa, MasterCard, Diners, American Express, JCB and all the major credit cards. Companiesandmarkets.com uses RBSWorldpay.
Once you have purchased your report(s), you will receive a confirmation email. You will then either be able to download your report(s) immediately from your Customer Area in PDF format, or the report(s) will be emailed to you directly, depending on the agreement we have with the publisher. Orders that are deliverable via email which are taken outside of working hours will be delivered next business day.
Please note, if you purchase by invoice, you will receive your report(s) once payment has been received. If you have any questions about how to order, please Contact Us.
